Monday, September 20, 2021 5:18:07 PM
Zoom presentation with Gain Therapeutics (Nasdaq: GANX) this Wednesday, 9/22 @ 4:00pm ET . The CEO Eric Richman will be updating investors and answering questions. Please register to attend the presentation using the link below:
https://www.eventbrite.com/e/gain-therapeutics-inc-webinar-9222021-registration-173949637047?utm_source=eventbrite&utm_medium=email&utm_content=follow_notification&utm_campaign=following_published_event&utm_term=Gain+Therapeutics%2C+Inc.-Webinar+9%2F22%2F2021&aff=ebemoffollowpublishemail
https://www.eventbrite.com/e/gain-therapeutics-inc-webinar-9222021-registration-173949637047?utm_source=eventbrite&utm_medium=email&utm_content=follow_notification&utm_campaign=following_published_event&utm_term=Gain+Therapeutics%2C+Inc.-Webinar+9%2F22%2F2021&aff=ebemoffollowpublishemail
Recent GANX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/11/2026 08:08:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/11/2026 08:05:35 PM
- Gain Therapeutics (GANX) Shares Edge Higher After Narrower-Than-Expected Q1 Loss • IH Market News • 05/11/2026 01:51:33 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/28/2026 08:49:27 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2026 08:47:26 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/28/2026 08:45:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 12:00:11 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 08:07:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:05:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2026 12:51:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/03/2026 09:25:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2025 02:00:45 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/03/2025 09:02:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2025 09:03:07 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/28/2025 09:01:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 09:09:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 09:06:47 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/07/2025 09:06:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 08:56:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/09/2025 08:30:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2025 09:01:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2025 08:05:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2025 08:03:31 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/17/2025 11:37:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2025 11:30:45 AM
